Cerebral Angiography Market by Product, Route of Administration, Application, End-User

KEY MARKET STATISTICS
Base Year [2023]	USD 1.41 billion
Estimated Year [2024]	USD 1.51 billion
Forecast Year [2030]	USD 2.25 billion
CAGR (%)	6.85%

The FPNV Positioning Matrix is pivotal in evaluating the Cerebral Angiography Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cerebral Angiography Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cerebral Angiography Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health, Inc., Carestream Health, Inc., Cook Group Incorporated, GE Healthcare Technologies Inc., Hitachi Medical Corporation, Hologic, Inc., InterMed Medical Limited, Koninklijke Philips N.V., MEDTRON AG, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Samsung Medison Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, St. Stone Medical Devices Private Limited, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cerebral Angiography Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Computed Tomography Angiography
- Magnetic Resonance Angiography
- X-ray Angiography
Route of Administration
- Transfemoral
- Transradial
Application
- Diagnostics
- Therapeutics
End-User
- Ambulatory Surgical Centers
- Hospitals & Clinics
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cerebral Angiography Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cerebral Angiography Market?

3. What are the technology trends and regulatory frameworks in the Cerebral Angiography Market?

4. What is the market share of the leading vendors in the Cerebral Angiography Market?

5. Which modes and strategic moves are suitable for entering the Cerebral Angiography Market?

Product Code: MRR-8E22B619331F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cerebral Angiography Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidence of cerebrovascular diseases and injuries
  - 5.1.1.2. Preference for minimally invasive and image-guided surgeries
  - 5.1.1.3. Initiatives to raise awareness and early diagnosis of brain disorders
- 5.1.2. Restraints
  - 5.1.2.1. Complex reimbursement for angiography procedures
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in cerebral angiography
  - 5.1.3.2. Expanding demand for hybrid angiography imaging systems
- 5.1.4. Challenges
  - 5.1.4.1. Potential side effects of undergoing cerebral angiography
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cerebral Angiography Market, by Product

6.1. Introduction
6.2. Computed Tomography Angiography
6.3. Magnetic Resonance Angiography
6.4. X-ray Angiography

7. Cerebral Angiography Market, by Route of Administration

7.1. Introduction
7.2. Transfemoral
7.3. Transradial

8. Cerebral Angiography Market, by Application

8.1. Introduction
8.2. Diagnostics
8.3. Therapeutics

9. Cerebral Angiography Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals & Clinics

10. Americas Cerebral Angiography Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Cerebral Angiography Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Cerebral Angiography Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. AngioDynamics, Inc.
- 14.1.3. B. Braun Melsungen AG
- 14.1.4. Becton, Dickinson and Company
- 14.1.5. Boston Scientific Corporation
- 14.1.6. Canon Medical Systems Corporation
- 14.1.7. Cardinal Health, Inc.
- 14.1.8. Carestream Health, Inc.
- 14.1.9. Cook Group Incorporated
- 14.1.10. GE Healthcare Technologies Inc.
- 14.1.11. Hitachi Medical Corporation
- 14.1.12. Hologic, Inc.
- 14.1.13. InterMed Medical Limited
- 14.1.14. Koninklijke Philips N.V.
- 14.1.15. MEDTRON AG
- 14.1.16. Medtronic PLC
- 14.1.17. Merit Medical Systems, Inc.
- 14.1.18. MicroPort Scientific Corporation
- 14.1.19. Penumbra, Inc.
- 14.1.20. Samsung Medison Co., Ltd.
- 14.1.21. Shimadzu Corporation
- 14.1.22. Siemens Healthineers company
- 14.1.23. St. Stone Medical Devices Private Limited
- 14.1.24. Stryker Corporation
- 14.1.25. Terumo Corporation
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing